12:01pm PDT - October 16th, 2022

RT @DrYukselUrun: No ORR, PFS, and OS differences between chemo and Rogaratinib (pan FGFR1-4 inhibitor) in patients with FGFR mRNA+ mUC pr…

0 retweets   1 likes  - Benjamin Auberger (@Benny8680)